Source link : https://newshealth.biz/health-news/mhra-approves-first-t1d-immunotherapy-in-uk/
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed for adults and children aged 8 years and older with stage 2 T1D to delay progression to stage 3. Teplizumab was approved in the US in […]
The post MHRA Approves First T1D Immunotherapy in UK first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-15 10:54:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8